πŸ‡ΊπŸ‡Έ FDA
Patent

US 12428416

ERK inhibitors and uses thereof

granted A61KA61K31/506A61K31/5377

Quick answer

US patent 12428416 (ERK inhibitors and uses thereof) held by The Regents of the University of California expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/506, A61K31/5377, A61P, A61P35/00